首页 产品目录 全部产品 (1R,2R,4S)-4-(((2R,4S,5S,6S)-4-(二甲氨基)-5-(((2S,4S,5S,6S)-4-羟基-6-甲基-5-(((2R,6S)-6-甲基-5-氧代四氢-2H-吡喃-2-基)氧基)四氢-2H-吡喃-2-基)氧基)-6-甲基四氢-2H-吡喃-2-基)氧基)-2-乙基-2,5,7-三羟基-6,11-二氧代-1,2,3,4,6,11-六氢并四苯-1-羧酸甲酯

(1R,2R,4S)-4-(((2R,4S,5S,6S)-4-(二甲氨基)-5-(((2S,4S,5S,6S)-4-羟基-6-甲基-5-(((2R,6S)-6-甲基-5-氧代四氢-2H-吡喃-2-基)氧基)四氢-2H-吡喃-2-基)氧基)-6-甲基四氢-2H-吡喃-2-基)氧基)-2-乙基-2,5,7-三羟基-6,11-二氧代-1,2,3,4,6,11-六氢并四苯-1-羧酸甲酯

methyl (1R,2R,4S)-4-(((2R,4S,5S,6S)-4-(dimethylamino)-5-(((2S,4S,5S,6S)-4-hydroxy-6-methyl-5-(((2R,6S)-6-methyl-5-oxotetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
1mg 95% 询价
- +
5mg 95% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

57576-44-0

中文名称

(1R,2R,4S)-4-(((2R,4S,5S,6S)-4-(二甲氨基)-5-(((2S,4S,5S,6S)-4-羟基-6-甲基-5-(((2R,6S)-6-甲基-5-氧代四氢-2H-吡喃-2-基)氧基)四氢-2H-吡喃-2-基)氧基)-6-甲基四氢-2H-吡喃-2-基)氧基)-2-乙基-2,5,7-三羟基-6,11-二氧代-1,2,3,4,6,11-六氢并四苯-1-羧酸甲酯

英文名称

methyl (1R,2R,4S)-4-(((2R,4S,5S,6S)-4-(dimethylamino)-5-(((2S,4S,5S,6S)-4-hydroxy-6-methyl-5-(((2R,6S)-6-methyl-5-oxotetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate

别名

1-naphthacenecarboxylicacid,2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6;aclacur;aclarubicinfreebase;antibiotic3082a;ACLARUBLCIN;ACLARUNBICIN;1-Naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy]-, methyl ester, [1R-(1α,2β,4β)]-;Jaclacin

标准英文名

methyl (1R,2R,4S)-4-(((2R,4S,5S,6S)-4-(dimethylamino)-5-(((2S,4S,5S,6S)-4-hydroxy-6-methyl-5-(((2R,6S)-6-methyl-5-oxotetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate

分子式

C42H53NO15

分子量

811.34

精确分子量

811.34

SMILES

COC([C@@H]1C2=C(C(O)=C3C(C(C4=CC=CC(O)=C4C3=O)=O)=C2)[C@H](C[C@]1(O)CC)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O[C@H]6C[C@@H]([C@@H]([C@@H](O6)C)O[C@@H]7O[C@H](C(CC7)=O)C)O)N(C)C)=O

标准SMILES

COC(=O)[C@@H]1C2C=C3C(C(=O)C4C(=CC=CC=4O)C3=O)=C(O)C=2[C@H](C[C@]1(O)CC)O[C@H]1C[C@@H]([C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3CCC(=O)[C@H](C)O3)[C@H](C)O2)[C@H](C)O1)N(C)C

用途

Aclarubicin is a second-generation anthracycline antitumor antibiotic and a cell cycle non-specific agent that inhibits the biosynthesis of DNA, RNA, and proteins. It exhibits potent anticancer activity and can be administered orally, with significantly lower cardiotoxicity compared to doxorubicin and without notable immunosuppressive or myelosuppressive effects. Clinically used as its hydrochloride salt, it shows high efficacy in inducing remission in acute leukemia and is also effective against endometrial cancer, hepatocellular carcinoma, gastrointestinal cancers, lung cancer, pancreatic cancer, ovarian cancer, and malignant lymphoma. It is primarily used as an antitumor antibiotic for the treatment of lung cancer, breast cancer, digestive tract cancers, and acute leukemia.

InChIKey

USZYSDMBJDPRIF-SVEJIMAYSA-N

安全信息

SureRoute逆合成路线

1.  57576-44-0 逆合成路线 1

—
—
—
—
ACEMEG735
57576-44-0
来源: SureRoute

2.  57576-44-0 逆合成路线 2

—
—
—
—
ACEMEG735
57576-44-0
来源: SureRoute

3.  57576-44-0 逆合成路线 3

—
—
ACEMEG735
57576-44-0
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手